Rudy Li
Stock Analyst at Chardan Capital
(n/a)
# 4,674
Out of 4,814 analysts
8
Total ratings
n/a
Success rate
-33.45%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rudy Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STOK Stoke Therapeutics | Maintains: Buy | $24 | $7.71 | +211.28% | 3 | Mar 19, 2025 | |
| PRTA Prothena Corporation | Maintains: Buy | $40 | $9.20 | +334.78% | 3 | Feb 21, 2025 | |
| MNMD Mind Medicine (MindMed) | Initiates: Buy | $20 | $5.77 | +246.62% | 2 | Dec 20, 2024 |
Stoke Therapeutics
Mar 19, 2025
Maintains: Buy
Price Target: $24
Current: $7.71
Upside: +211.28%
Prothena Corporation
Feb 21, 2025
Maintains: Buy
Price Target: $40
Current: $9.20
Upside: +334.78%
Mind Medicine (MindMed)
Dec 20, 2024
Initiates: Buy
Price Target: $20
Current: $5.77
Upside: +246.62%